Aggressive CNS lupus vasculitis in the absence of systemic disease activity.
Department of Molecular Neuroscience and Centre for Neuromuscular Disease, Institute of Neurology and the National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.
C M
CM
Everett
T D
TD
Graves
S
S
Lad
H R
HR
Jäger
M
M
Thom
D A
DA
Isenberg
M G
MG
Hanna
D000927:Anticonvulsants / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D001379:Azathioprine / Q000627:therapeutic use; D001921:Brain / Q000473:pathology* / Q000503:physiopathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007275:Injections, Intravenous; D020945:Lupus Vasculitis, Central Nervous System / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D012640:Seizures / Q000175:diagnosis / Q000209:etiology; D012698:Serologic Tests; D016896:Treatment Outcome
D000927:Anticonvulsants; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D018696:Neuroprotective Agents; D010672:Phenytoin; D003520:Cyclophosphamide; D001379:Azathioprine; D008775:Methylprednisolone